Breaking News

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its new state-of-the-art Technology Centre in Hyderabad, marking a significant milestone in...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia

Johnson & Johnson announced the presentation of comprehensive new clinical and real-world data across its industry-leading neuropsychiatry portfolio...

India Targets 100 New Biologic Medicines by 2047 Under Biopharma SHAKTI

At the landmark 2nd Pharma Summit & Awards 2026 organized by the Associated Chambers of Commerce and Industry of India (ASSOCHAM), the Government of...

Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times

Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded its Initial Public Offering (IPO) with resounding success, achieving an overall subscription of 53.68 times...

AstraZeneca Advances Oral GLP-1 Elecoglipron to Phase III Programme

AstraZeneca  announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...

Sun Pharma Gets SBI Support for $12 Billion Organon Acquisition

State Bank of India (SBI) is set to join a global consortium financing Sun Pharmaceutical Industries Ltd.'s landmark USD 12 billion acquisition of Organon & Co.,...

ICMR Study Focuses on Vitamin Intake and Diet Diversity

A groundbreaking community-based study conducted by the ICMR-National Institute of Nutrition (ICMR-NIN) has established a significant connection between poor micronutrient status and a higher...

GSK expands deal worth $ 10.6B for lung cancer treatment

GSK plc and Nuvalent, Inc. announced that they have entered into a definitive agreement under which GSK will acquire Nuvalent, a clinical-stage biopharmaceutical company focused on...